Lymphocytic Neoplasm

Peripheral T-Cell Lymphoma, Not Otherwise Specified

← altered in cohorts of

PRSS2

41 / 58 cases (71 %) · ssm · RC-PTCL

—

Observed

Peripheral T-Cell Lymphoma, Not Otherwise Specified

← altered in cohorts of

MTRNR2L6

38 / 58 cases (66 %) · ssm · RC-PTCL

—

Observed

← altered in cohorts of

IGHV2-70

437 / 961 cases (45 %) · ssm · MMRF-COMMPASS · largest of 2 cohorts

—

Observed

B-Cell Non-Hodgkin Lymphoma

← altered in cohorts of

DDX3X

124 / 297 cases (42 %) · ssm · mbn_sfu_2023

—

Observed

cbioportal

← altered in cohorts of

IGLV3-1

364 / 961 cases (38 %) · ssm · MMRF-COMMPASS · largest of 2 cohorts

—

Observed

Peripheral T-Cell Lymphoma, Not Otherwise Specified

← altered in cohorts of

POTEM

20 / 58 cases (34 %) · ssm · RC-PTCL

—

Observed

← altered in cohorts of

SHCBP1

73 / 263 cases (28 %) · ssm · CGCI-BLGSP

—

Observed

← altered in cohorts of

VPS35

67 / 263 cases (25 %) · ssm · CGCI-BLGSP

—

Observed

← altered in cohorts of

ORC6

66 / 263 cases (25 %) · ssm · CGCI-BLGSP

—

Observed

← altered in cohorts of

TPTE

66 / 263 cases (25 %) · ssm · CGCI-BLGSP

—

Observed

← altered in cohorts of

IGHV2-70D

238 / 961 cases (25 %) · ssm · MMRF-COMMPASS · largest of 2 cohorts

—

Observed

Diffuse Large B-Cell Lymphoma Unclassifiable

← altered in cohorts of

KMT2D

247 / 1,001 cases (25 %) · ssm · dlbcl_duke_2017 · largest of 6 cohorts

—

Observed

cbioportal

← altered in cohorts of

KRAS

227 / 961 cases (24 %) · ssm · MMRF-COMMPASS · largest of 3 cohorts

—

Observed

← altered in cohorts of

MYLK3

62 / 263 cases (24 %) · ssm · CGCI-BLGSP

—

Observed

Lymphocytic Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 323show all (up to 200)
→ investigated in trials for	Cyclophosphamidesmall molecule 942 trials (225 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	942	Observed	clinicaltrials	graph →
→ investigated in trials for	Dexamethasonesmall molecule 908 trials (277 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	908	Observed	clinicaltrials	graph →
→ investigated in trials for	Rituximabmonoclonal antibody 813 trials (189 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	813	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenalidomidesmall molecule 584 trials (198 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	584	Observed	clinicaltrials	graph →
→ investigated in trials for	Bortezomibsmall molecule 503 trials (105 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	503	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall molecule 456 trials (107 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	456	Observed	clinicaltrials	graph →
→ investigated in trials for	Doxorubicinsmall molecule 391 trials (97 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	391	Observed	clinicaltrials	graph →
→ investigated in trials for	Vincristinesmall molecule 377 trials (89 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	377	Observed	clinicaltrials	graph →
→ investigated in trials for	Etoposidesmall molecule 361 trials (55 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	361	Observed	clinicaltrials	graph →
→ investigated in trials for	Prednisonesmall molecule 344 trials (92 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	344	Observed	clinicaltrials	graph →
→ investigated in trials for	Melphalansmall molecule 310 trials (33 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	310	Observed	clinicaltrials	graph →
→ investigated in trials for	Filgrastimother 257 trials (11 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	257	Observed	clinicaltrials	graph →
→ investigated in trials for	Cytarabinesmall molecule 253 trials (45 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	253	Observed	clinicaltrials	graph →
→ investigated in trials for	Methotrexatesmall molecule 240 trials (49 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	240	Observed	clinicaltrials	graph →
→ investigated in trials for	Daratumumabmonoclonal antibody 229 trials (125 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	229	Observed	clinicaltrials	graph →
→ investigated in trials for	Pomalidomidesmall molecule 200 trials (86 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	200	Observed	clinicaltrials	graph →
→ investigated in trials for	Carfilzomibother 183 trials (68 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	183	Observed	clinicaltrials	graph →
→ investigated in trials for	Ibrutinibsmall molecule 174 trials (61 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	174	Observed	clinicaltrials	graph →
→ investigated in trials for	Venetoclaxsmall molecule 166 trials (97 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	166	Observed	clinicaltrials	graph →
→ investigated in trials for	Bendamustinesmall molecule 161 trials (51 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	161	Observed	clinicaltrials	graph →
→ investigated in trials for	Obinutuzumabmonoclonal antibody 138 trials (75 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	138	Observed	clinicaltrials	graph →
→ investigated in trials for	Busulfansmall molecule 132 trials (14 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	132	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal antibody 115 trials (38 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	115	Observed	clinicaltrials	graph →
→ investigated in trials for	Gemcitabinesmall molecule 114 trials (20 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	114	Observed	clinicaltrials	graph →
→ investigated in trials for	Carmustinesmall molecule 100 trials (4 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	100	Observed	clinicaltrials	graph →
→ investigated in trials for	Thalidomidesmall molecule 100 trials (6 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	100	Observed	clinicaltrials	graph →
→ investigated in trials for	Ixazomibsmall molecule 91 trials (16 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	91	Observed	clinicaltrials	graph →
→ investigated in trials for	Nivolumabmonoclonal antibody 86 trials (31 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	86	Observed	clinicaltrials	graph →
→ investigated in trials for	Brentuximab Vedotinadc 83 trials (24 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	83	Observed	clinicaltrials	graph →
→ investigated in trials for	Ifosfamidesmall molecule 81 trials (13 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	81	Observed	clinicaltrials	graph →
→ investigated in trials for	Leucovorinsmall molecule 76 trials (12 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	76	Observed	clinicaltrials	graph →
→ investigated in trials for	Zanubrutinibsmall molecule 74 trials (55 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	74	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall molecule 70 trials (10 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	70	Observed	clinicaltrials	graph →
→ investigated in trials for	Belantamab Mafodotinadc 62 trials (40 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	62	Observed	clinicaltrials	graph →
→ investigated in trials for	Isatuximabmonoclonal antibody 60 trials (46 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	60	Observed	clinicaltrials	graph →
→ investigated in trials for	Alemtuzumabmonoclonal antibody 59 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	59	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 58 trials (10 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	58	Observed	clinicaltrials	graph →
→ investigated in trials for	Elotuzumabmonoclonal antibody 58 trials (18 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	58	Observed	clinicaltrials	graph →
→ investigated in trials for	Acalabrutinibsmall molecule 57 trials (42 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	57	Observed	clinicaltrials	graph →
→ investigated in trials for	Selinexorsmall molecule 56 trials (26 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	56	Observed	clinicaltrials	graph →
→ investigated in trials for	Prednisolonesmall molecule 55 trials (13 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	55	Observed	clinicaltrials	graph →
→ investigated in trials for	Vorinostatsmall molecule 55 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	55	Observed	clinicaltrials	graph →
→ investigated in trials for	Blinatumomabmonoclonal antibody 54 trials (35 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	54	Observed	clinicaltrials	graph →
→ investigated in trials for	Pegaspargaseother 53 trials (17 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	53	Observed	clinicaltrials	graph →
→ investigated in trials for	Bleomycin 52 trials (6 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	52	Observed	clinicaltrials	graph →
→ investigated in trials for	Mercaptopurinesmall molecule 52 trials (21 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	52	Observed	clinicaltrials	graph →
→ investigated in trials for	Romidepsinother 51 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	51	Observed	clinicaltrials	graph →
→ investigated in trials for	Teclistamabmonoclonal antibody 51 trials (47 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	51	Observed	clinicaltrials	graph →
→ investigated in trials for	Vinblastinesmall molecule 49 trials (12 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	49	Observed	clinicaltrials	graph →
→ investigated in trials for	Azacitidinesmall molecule 47 trials (16 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	47	Observed	clinicaltrials	graph →
→ investigated in trials for	Pegfilgrastimother 47 trials (9 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	47	Observed	clinicaltrials	graph →
→ investigated in trials for	Elranatamabmonoclonal antibody 46 trials (37 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	46	Observed	clinicaltrials	graph →
→ investigated in trials for	Sirolimussmall molecule 44 trials (8 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	44	Observed	clinicaltrials	graph →
→ investigated in trials for	Panobinostatsmall molecule 43 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	43	Observed	clinicaltrials	graph →
→ investigated in trials for	Thiotepasmall molecule 42 trials (6 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	42	Observed	clinicaltrials	graph →
→ investigated in trials for	Aldesleukinother 40 trials (4 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	40	Observed	clinicaltrials	graph →
→ investigated in trials for	Dacarbazinesmall molecule 40 trials (12 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	40	Observed	clinicaltrials	graph →
→ investigated in trials for	Pirtobrutinibsmall molecule 40 trials (34 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	40	Observed	clinicaltrials	graph →
→ investigated in trials for	Epcoritamabmonoclonal antibody 39 trials (34 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	39	Observed	clinicaltrials	graph →
→ investigated in trials for	Glofitamabmonoclonal antibody 39 trials (30 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	39	Observed	clinicaltrials	graph →
→ investigated in trials for	Ofatumumabmonoclonal antibody 39 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	39	Observed	clinicaltrials	graph →
→ investigated in trials for	Daunorubicinsmall molecule 36 trials (13 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	36	Observed	clinicaltrials	graph →
→ investigated in trials for	Mosunetuzumabmonoclonal antibody 36 trials (32 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	36	Observed	clinicaltrials	graph →
→ investigated in trials for	Plerixaforsmall molecule 36 trials (4 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	36	Observed	clinicaltrials	graph →
→ investigated in trials for	Mitoxantronesmall molecule 34 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	34	Observed	clinicaltrials	graph →
→ investigated in trials for	Procarbazinesmall molecule 34 trials (4 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	34	Observed	clinicaltrials	graph →
→ investigated in trials for	Polatuzumab Vedotinadc 32 trials (22 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	32	Observed	clinicaltrials	graph →
→ investigated in trials for	Talquetamabmonoclonal antibody 32 trials (27 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	32	Observed	clinicaltrials	graph →
→ investigated in trials for	Dasatinibsmall molecule 31 trials (11 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	31	Observed	clinicaltrials	graph →
→ investigated in trials for	Duvelisibsmall molecule 31 trials (10 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	31	Observed	clinicaltrials	graph →
→ investigated in trials for	Oxaliplatinsmall molecule 29 trials (9 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	29	Observed	clinicaltrials	graph →
→ investigated in trials for	Idelalisibsmall molecule 28 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	28	Observed	clinicaltrials	graph →
→ investigated in trials for	Everolimussmall molecule 27 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	27	Observed	clinicaltrials	graph →
→ investigated in trials for	Inotuzumab Ozogamicinadc 27 trials (13 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	27	Observed	clinicaltrials	graph →
→ investigated in trials for	Thioguaninesmall molecule 27 trials (12 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	27	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipilimumabmonoclonal antibody 24 trials (5 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	24	Observed	clinicaltrials	graph →
→ investigated in trials for	Tafasitamabmonoclonal antibody 24 trials (18 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	24	Observed	clinicaltrials	graph →
→ investigated in trials for	Clofarabinesmall molecule 23 trials (3 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	23	Observed	clinicaltrials	graph →
→ investigated in trials for	Pralatrexatesmall molecule 23 trials (6 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	23	Observed	clinicaltrials	graph →
→ investigated in trials for	Tazemetostatsmall molecule 23 trials (9 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	23	Observed	clinicaltrials	graph →
→ investigated in trials for	Asparaginaseother 22 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	22	Observed	clinicaltrials	graph →
→ investigated in trials for	Belinostatsmall molecule 22 trials (5 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	22	Observed	clinicaltrials	graph →
→ investigated in trials for	Durvalumabmonoclonal antibody 22 trials (3 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	22	Observed	clinicaltrials	graph →
→ investigated in trials for	Temsirolimussmall molecule 22 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	22	Observed	clinicaltrials	graph →
→ investigated in trials for	Zoledronic Acidsmall molecule 22 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	22	Observed	clinicaltrials	graph →
→ investigated in trials for	Copanlisibsmall molecule 21 trials (7 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Mogamulizumabmonoclonal antibody 21 trials (6 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Ruxolitinibsmall molecule 21 trials (12 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Temozolomidesmall molecule 21 trials (4 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Axicabtagene Ciloleucelgene therapy 20 trials (11 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	20	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody 20 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	20	Observed	clinicaltrials	graph →
→ investigated in trials for	CHOP Regimen 20 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	20	Observed	clinicaltrials	graph →
→ investigated in trials for	Pentostatinsmall molecule 20 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	20	Observed	clinicaltrials	graph →
→ investigated in trials for	Tisagenlecleucelcell therapy 19 trials (5 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	19	Observed	clinicaltrials	graph →
→ investigated in trials for	Vinorelbinesmall molecule 19 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	19	Observed	clinicaltrials	graph →
→ investigated in trials for	Chemotherapy 18 trials (5 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	18	Observed	clinicaltrials	graph →
→ investigated in trials for	Ibritumomab Tiuxetanmonoclonal antibody 18 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	18	Observed	clinicaltrials	graph →
→ investigated in trials for	Nelarabinesmall molecule 18 trials (4 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	18	Observed	clinicaltrials	graph →
→ investigated in trials for	Paclitaxelsmall molecule 18 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	18	Observed	clinicaltrials	graph →
→ investigated in trials for	Alisertibsmall molecule 17 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	17	Observed	clinicaltrials	graph →
→ investigated in trials for	Cladribinesmall molecule 17 trials (5 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	17	Observed	clinicaltrials	graph →
→ investigated in trials for	Lisocabtagene Maraleucelgene therapy 17 trials (10 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	17	Observed	clinicaltrials	graph →
→ investigated in trials for	Atezolizumabmonoclonal antibody 16 trials (3 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Chlorambucilsmall molecule 16 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Linvoseltamabmonoclonal antibody 16 trials (14 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Topotecansmall molecule 16 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Arsenic Trioxidesmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	15	Observed	clinicaltrials	graph →
→ investigated in trials for	Tislelizumabmonoclonal antibody 15 trials (6 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	15	Observed	clinicaltrials	graph →
→ investigated in trials for	Alvocidibsmall molecule 14 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	14	Observed	clinicaltrials	graph →
→ investigated in trials for	Calaspargase Pegolother 14 trials (12 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	14	Observed	clinicaltrials	graph →
→ investigated in trials for	Decitabinesmall molecule 14 trials (4 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	14	Observed	clinicaltrials	graph →
→ investigated in trials for	Loncastuximab Tesirineadc 14 trials (8 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	14	Observed	clinicaltrials	graph →
→ investigated in trials for	Crizotinibsmall molecule 13 trials (7 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Idecabtagene Vicleucelgene therapy 13 trials (6 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Palbociclibsmall molecule 13 trials (6 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Irinotecansmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Odronextamabmonoclonal antibody 11 trials (9 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Tanespimycinsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Trametinibsmall molecule 11 trials (8 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Vindesinesmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Bexarotenesmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Enzastaurinsmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Mechlorethaminesmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Nirogacestatsmall molecule 10 trials (8 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Perifosinesmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Sunitinibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Tretinoinsmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Camrelizumabmonoclonal antibody 9 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Idarubicinsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Aspirinsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Avelumabmonoclonal antibody 8 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Brexucabtagene Autoleucelgene therapy 8 trials (4 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Ciltacabtagene Autoleucelgene therapy 8 trials (6 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Imatinib Mesylatesmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Lomustinesmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Sintilimabmonoclonal antibody 8 trials (3 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Dinaciclibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Epirubicinsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Fluorouracilsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Metforminsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Nilotinibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Pemetrexedsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Ponatinibsmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Vemurafenibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Abexinostatsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Cemiplimabmonoclonal antibody 6 trials (5 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Denosumabmonoclonal antibody 6 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Melphalan Flufenamidesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Nab-paclitaxel 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Pacritinibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Veliparibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Vismodegibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Abemaciclibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Binimetinibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Buparlisibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Cabozantinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Celecoxibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Dabrafenibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Docetaxelsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Moxetumomab Pasudotoxadc 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	O6-Benzylguaninesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Sapanisertibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenib Tosylatesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Tipifarnibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Toripalimabmonoclonal antibody 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Afatinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Anti-PD1 Monoclonal Antibody 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Bimiralisibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Dordavipronesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Olaparibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Peginterferon Alfa-2bother 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Pixantronesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Radiation Therapy 4 trials (3 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Ridaforolimussmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Teniposidesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Valproic Acidsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Afliberceptother 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Akt Inhibitor MK2206 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Alectinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Alvespimycinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Brigatinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Capecitabinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Capivasertibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Cobimetinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Enzalutamidesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Erdafitinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Hematopoietic Cell Transplantation 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Hydroxychloroquinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	HyperCVAD Regimen 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Imatinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Immunotherapy 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Interferon Alfa-2bother 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenvatinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Navtemadlinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Pixantrone Dimaleatesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumab Emtansineadc 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Treosulfansmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Lymphocytic Neoplasm	3	Observed	clinicaltrials	graph →

Lymphocytic Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 323show all (up to 200)

→ investigated in trials for

Cyclophosphamidesmall molecule

942 trials (225 active) · roll-up of the cancer and its descendants

—

942

Observed

→ investigated in trials for

Dexamethasonesmall molecule

908 trials (277 active) · roll-up of the cancer and its descendants

—

908

Observed

→ investigated in trials for

Rituximabmonoclonal antibody

813 trials (189 active) · roll-up of the cancer and its descendants

—

813

Observed

→ investigated in trials for

Lenalidomidesmall molecule

584 trials (198 active) · roll-up of the cancer and its descendants

—

584

Observed

→ investigated in trials for

Bortezomibsmall molecule

503 trials (105 active) · roll-up of the cancer and its descendants

—

503

Observed

→ investigated in trials for

Fludarabinesmall molecule

456 trials (107 active) · roll-up of the cancer and its descendants

—

456

Observed

→ investigated in trials for

Doxorubicinsmall molecule

391 trials (97 active) · roll-up of the cancer and its descendants

—

391

Observed

→ investigated in trials for

Vincristinesmall molecule

377 trials (89 active) · roll-up of the cancer and its descendants

—

377

Observed

→ investigated in trials for

Etoposidesmall molecule

361 trials (55 active) · roll-up of the cancer and its descendants

—

361

Observed

→ investigated in trials for

Prednisonesmall molecule

344 trials (92 active) · roll-up of the cancer and its descendants

—

344

Observed

→ investigated in trials for

Melphalansmall molecule

310 trials (33 active) · roll-up of the cancer and its descendants

—

310

Observed

→ investigated in trials for

Filgrastimother

257 trials (11 active) · roll-up of the cancer and its descendants

—

257

Observed

→ investigated in trials for

Cytarabinesmall molecule

253 trials (45 active) · roll-up of the cancer and its descendants

—

253

Observed

→ investigated in trials for

Methotrexatesmall molecule

240 trials (49 active) · roll-up of the cancer and its descendants

—

240

Observed

→ investigated in trials for

Daratumumabmonoclonal antibody

229 trials (125 active) · roll-up of the cancer and its descendants

—

229

Observed

→ investigated in trials for

Pomalidomidesmall molecule

200 trials (86 active) · roll-up of the cancer and its descendants

—

200

Observed

→ investigated in trials for

Carfilzomibother

183 trials (68 active) · roll-up of the cancer and its descendants

—

183

Observed

→ investigated in trials for

Ibrutinibsmall molecule

174 trials (61 active) · roll-up of the cancer and its descendants

—

174

Observed

→ investigated in trials for

Venetoclaxsmall molecule

166 trials (97 active) · roll-up of the cancer and its descendants

—

166

Observed

→ investigated in trials for

Bendamustinesmall molecule

161 trials (51 active) · roll-up of the cancer and its descendants

—

161

Observed

→ investigated in trials for

Obinutuzumabmonoclonal antibody

138 trials (75 active) · roll-up of the cancer and its descendants

—

138

Observed

→ investigated in trials for

Busulfansmall molecule

132 trials (14 active) · roll-up of the cancer and its descendants

—

132

Observed

→ investigated in trials for

Pembrolizumabmonoclonal antibody

115 trials (38 active) · roll-up of the cancer and its descendants

—

115

Observed

→ investigated in trials for

Gemcitabinesmall molecule

114 trials (20 active) · roll-up of the cancer and its descendants

—

114

Observed

→ investigated in trials for

Carmustinesmall molecule

100 trials (4 active) · roll-up of the cancer and its descendants

—

100

Observed

→ investigated in trials for

Thalidomidesmall molecule

100 trials (6 active) · roll-up of the cancer and its descendants

—

100

Observed

→ investigated in trials for

Ixazomibsmall molecule

91 trials (16 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal antibody

86 trials (31 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Brentuximab Vedotinadc

83 trials (24 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ifosfamidesmall molecule

81 trials (13 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Leucovorinsmall molecule

76 trials (12 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Zanubrutinibsmall molecule

74 trials (55 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cisplatinsmall molecule

70 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Belantamab Mafodotinadc

62 trials (40 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Isatuximabmonoclonal antibody

60 trials (46 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alemtuzumabmonoclonal antibody

59 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carboplatinsmall molecule

58 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Elotuzumabmonoclonal antibody

58 trials (18 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Acalabrutinibsmall molecule

57 trials (42 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selinexorsmall molecule

56 trials (26 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Prednisolonesmall molecule

55 trials (13 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vorinostatsmall molecule

55 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Blinatumomabmonoclonal antibody

54 trials (35 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pegaspargaseother

53 trials (17 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bleomycin

52 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mercaptopurinesmall molecule

52 trials (21 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Romidepsinother

51 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Teclistamabmonoclonal antibody

51 trials (47 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vinblastinesmall molecule

49 trials (12 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Azacitidinesmall molecule

47 trials (16 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pegfilgrastimother

47 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Elranatamabmonoclonal antibody

46 trials (37 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sirolimussmall molecule

44 trials (8 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Panobinostatsmall molecule

43 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Thiotepasmall molecule

42 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aldesleukinother

40 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dacarbazinesmall molecule

40 trials (12 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pirtobrutinibsmall molecule

40 trials (34 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Epcoritamabmonoclonal antibody

39 trials (34 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Glofitamabmonoclonal antibody

39 trials (30 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ofatumumabmonoclonal antibody

39 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Daunorubicinsmall molecule

36 trials (13 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mosunetuzumabmonoclonal antibody

36 trials (32 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Plerixaforsmall molecule

36 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mitoxantronesmall molecule

34 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Procarbazinesmall molecule

34 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Polatuzumab Vedotinadc

32 trials (22 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Talquetamabmonoclonal antibody

32 trials (27 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dasatinibsmall molecule

31 trials (11 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Duvelisibsmall molecule

31 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Oxaliplatinsmall molecule

29 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Idelalisibsmall molecule

28 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Everolimussmall molecule

27 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Inotuzumab Ozogamicinadc

27 trials (13 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Thioguaninesmall molecule

27 trials (12 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipilimumabmonoclonal antibody

24 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tafasitamabmonoclonal antibody

24 trials (18 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Clofarabinesmall molecule

23 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pralatrexatesmall molecule

23 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tazemetostatsmall molecule

23 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Asparaginaseother

22 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Belinostatsmall molecule

22 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Durvalumabmonoclonal antibody

22 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temsirolimussmall molecule

22 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Zoledronic Acidsmall molecule

22 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Copanlisibsmall molecule

21 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mogamulizumabmonoclonal antibody

21 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ruxolitinibsmall molecule

21 trials (12 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temozolomidesmall molecule

21 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Axicabtagene Ciloleucelgene therapy

20 trials (11 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bevacizumabmonoclonal antibody

20 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

CHOP Regimen

20 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pentostatinsmall molecule

20 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tisagenlecleucelcell therapy

19 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vinorelbinesmall molecule

19 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Chemotherapy

18 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ibritumomab Tiuxetanmonoclonal antibody

18 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nelarabinesmall molecule

18 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Paclitaxelsmall molecule

18 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alisertibsmall molecule

17 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cladribinesmall molecule

17 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lisocabtagene Maraleucelgene therapy

17 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Atezolizumabmonoclonal antibody

16 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Chlorambucilsmall molecule

16 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Linvoseltamabmonoclonal antibody

16 trials (14 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Topotecansmall molecule

16 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Arsenic Trioxidesmall molecule

15 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tislelizumabmonoclonal antibody

15 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alvocidibsmall molecule

14 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Calaspargase Pegolother

14 trials (12 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Decitabinesmall molecule

14 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Loncastuximab Tesirineadc

14 trials (8 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Crizotinibsmall molecule

13 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Idecabtagene Vicleucelgene therapy

13 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Palbociclibsmall molecule

13 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Irinotecansmall molecule

11 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Odronextamabmonoclonal antibody

11 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tanespimycinsmall molecule

11 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trametinibsmall molecule

11 trials (8 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vindesinesmall molecule

11 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bexarotenesmall molecule

10 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enzastaurinsmall molecule

10 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mechlorethaminesmall molecule

10 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nirogacestatsmall molecule

10 trials (8 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Perifosinesmall molecule

10 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sunitinibsmall molecule

10 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tretinoinsmall molecule

10 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Camrelizumabmonoclonal antibody

9 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Idarubicinsmall molecule

9 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aspirinsmall molecule

8 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Avelumabmonoclonal antibody

8 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Brexucabtagene Autoleucelgene therapy

8 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ciltacabtagene Autoleucelgene therapy

8 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Imatinib Mesylatesmall molecule

8 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lomustinesmall molecule

8 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sintilimabmonoclonal antibody

8 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dinaciclibsmall molecule

7 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Epirubicinsmall molecule

7 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fluorouracilsmall molecule

7 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Metforminsmall molecule

7 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nilotinibsmall molecule

7 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pemetrexedsmall molecule

7 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ponatinibsmall molecule

7 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vemurafenibsmall molecule

7 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abexinostatsmall molecule

6 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cemiplimabmonoclonal antibody

6 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Denosumabmonoclonal antibody

6 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Melphalan Flufenamidesmall molecule

6 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nab-paclitaxel

6 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pacritinibsmall molecule

6 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Veliparibsmall molecule

6 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vismodegibsmall molecule

6 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abemaciclibsmall molecule

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Binimetinibsmall molecule

5 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Buparlisibsmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cabozantinibsmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Celecoxibsmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dabrafenibsmall molecule

5 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Docetaxelsmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Moxetumomab Pasudotoxadc

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

O6-Benzylguaninesmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sapanisertibsmall molecule

5 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenib Tosylatesmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tipifarnibsmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Toripalimabmonoclonal antibody

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Afatinibsmall molecule

4 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

Anti-PD1 Monoclonal Antibody

→ investigated in trials for

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bimiralisibsmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dordavipronesmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Olaparibsmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Peginterferon Alfa-2bother

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pixantronesmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Radiation Therapy

4 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ridaforolimussmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Teniposidesmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Valproic Acidsmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Afliberceptother

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Akt Inhibitor MK2206

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alectinibsmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alvespimycinsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Brigatinibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capecitabinesmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capivasertibsmall molecule

3 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cobimetinibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enzalutamidesmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erdafitinibsmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erlotinibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Hematopoietic Cell Transplantation

→ investigated in trials for

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Hydroxychloroquinesmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

HyperCVAD Regimen

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Imatinibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Immunotherapy

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Interferon Alfa-2bother

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenvatinibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Navtemadlinsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pixantrone Dimaleatesmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trastuzumabmonoclonal antibody

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trastuzumab Emtansineadc

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Treosulfansmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

Lymphocytic Neoplasm studied in …STUDIED_INderived10 of 9,160show all (up to 200)
→ studied in	NCT00423644Phase 2 · completed A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b · condition mapped CURATED_EXACT · 9,160 trials mapped (2,594 active)	—	—	Multiple Myeloma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00592163Phase 1 · completed Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas · condition mapped ONTOLOGY_EXACT · 9,160 trials mapped (2,594 active)	—	—	Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01414855Phase 2 · completed A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER) · condition mapped CURATED_BROADER · 9,160 trials mapped (2,594 active)	—	—	B-Cell Malignant Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT01559935Phase 2 · completed Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma · condition mapped CURATED_EXACT · 9,160 trials mapped (2,594 active)	—	—	Multiple Myeloma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01896999Phase 1/Phase 2 · active not recruiting Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma · condition mapped CURATED_BROADER · 9,160 trials mapped (2,594 active)	—	—	Classic Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped CURATED_BROADER · 9,160 trials mapped (2,594 active)	—	—	Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03739814Phase 2 · recruiting Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 9,160 trials mapped (2,594 active)	—	—	B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative	1	Observed	clinicaltrials	graph →
→ studied in	NCT04231877Phase 1 · active not recruiting Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 9,160 trials mapped (2,594 active)	—	—	Aggressive Non-Hodgkin Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05228470Phase 2 · completed A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma. · condition mapped ALIAS · 9,160 trials mapped (2,594 active)	—	—	Multiple Myeloma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05354557Phase 2 · active not recruiting Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT) · condition mapped CURATED_EXACT · 9,160 trials mapped (2,594 active)	—	—	Multiple Myeloma	1	Observed	clinicaltrials	graph →

Lymphocytic Neoplasm studied in …STUDIED_INderived10 of 9,160show all (up to 200)

→ studied in

NCT00423644Phase 2 · completed

A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b · condition mapped CURATED_EXACT · 9,160 trials mapped (2,594 active)

—

Observed

→ studied in

NCT00592163Phase 1 · completed

Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas · condition mapped ONTOLOGY_EXACT · 9,160 trials mapped (2,594 active)

—

Lymphoma

Observed

B-Cell Malignant Neoplasm

→ studied in

NCT01414855Phase 2 · completed

A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER) · condition mapped CURATED_BROADER · 9,160 trials mapped (2,594 active)

—

Observed

→ studied in

NCT01559935Phase 2 · completed

Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma · condition mapped CURATED_EXACT · 9,160 trials mapped (2,594 active)

—

Observed

→ studied in

NCT01896999Phase 1/Phase 2 · active not recruiting

Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma · condition mapped CURATED_BROADER · 9,160 trials mapped (2,594 active)

—

Classic Hodgkin Lymphoma

Observed

→ studied in

NCT02465060Phase 2 · active not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped CURATED_BROADER · 9,160 trials mapped (2,594 active)

—

Lymphoma

Observed

B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

→ studied in

NCT03739814Phase 2 · recruiting

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 9,160 trials mapped (2,594 active)

—

Observed

Aggressive Non-Hodgkin Lymphoma

→ studied in

NCT04231877Phase 1 · active not recruiting

Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 9,160 trials mapped (2,594 active)

—

Observed

→ studied in

NCT05228470Phase 2 · completed

A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma. · condition mapped ALIAS · 9,160 trials mapped (2,594 active)

—

Observed

→ studied in

NCT05354557Phase 2 · active not recruiting

Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT) · condition mapped CURATED_EXACT · 9,160 trials mapped (2,594 active)

—

Observed